REGULATORY INTELLIGENCE·Warning Letter
FDA Recall: Wuhan Bingbing Pharmaceutical's CGMP Failures Impact US Mencaine Patch Supply
Wuhan Bingbing Pharmaceutical Co., Ltd. initiated a Class II recall of Mencaine Patches due to critical CGMP deviations, specifically lost manufacturing records and retain samples. This impacts 1,800 pouches distributed nationwide in the USA, manufactured for Terrain Pharmaceuticals. This event underscores persistent global supply chain vulnerabilities and demands heightened due diligence from procurement and regulatory teams.
90-Day Activity